These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

2100 related items for PubMed ID: 30653341

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Hepatic transcriptome signature correlated with HOMA-IR explains early nonalcoholic fatty liver disease pathogenesis.
    Chatterjee A, Basu A, Das K, Singh P, Mondal D, Bhattacharya B, Roychoudhury S, Majumder PP, Chowdhury A, Basu P.
    Ann Hepatol; 2020; 19(5):472-481. PubMed ID: 32682086
    [Abstract] [Full Text] [Related]

  • 4. Nonalcoholic Fatty Liver Disease and Staging of Hepatic Fibrosis.
    Engin A.
    Adv Exp Med Biol; 2024; 1460():539-574. PubMed ID: 39287864
    [Abstract] [Full Text] [Related]

  • 5. The American lifestyle-induced obesity syndrome diet in male and female rodents recapitulates the clinical and transcriptomic features of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.
    Harris SE, Poolman TM, Arvaniti A, Cox RD, Gathercole LL, Tomlinson JW.
    Am J Physiol Gastrointest Liver Physiol; 2020 Sep 01; 319(3):G345-G360. PubMed ID: 32755310
    [Abstract] [Full Text] [Related]

  • 6. Evidence of NAFLD progression from steatosis to fibrosing-steatohepatitis using paired biopsies: implications for prognosis and clinical management.
    McPherson S, Hardy T, Henderson E, Burt AD, Day CP, Anstee QM.
    J Hepatol; 2015 May 01; 62(5):1148-55. PubMed ID: 25477264
    [Abstract] [Full Text] [Related]

  • 7. LC-MS-based lipidomic analysis in distinguishing patients with nonalcoholic steatohepatitis from nonalcoholic fatty liver.
    Wang ZH, Zheng KI, Wang XD, Qiao J, Li YY, Zhang L, Zheng MH, Wu J.
    Hepatobiliary Pancreat Dis Int; 2021 Oct 01; 20(5):452-459. PubMed ID: 34256994
    [Abstract] [Full Text] [Related]

  • 8. Nonalcoholic Fatty Liver Disease: Basic Pathogenetic Mechanisms in the Progression From NAFLD to NASH.
    Pierantonelli I, Svegliati-Baroni G.
    Transplantation; 2019 Jan 01; 103(1):e1-e13. PubMed ID: 30300287
    [Abstract] [Full Text] [Related]

  • 9. Ultra-high-field magnetic resonance spectroscopy in non-alcoholic fatty liver disease: Novel mechanistic and diagnostic insights of energy metabolism in non-alcoholic steatohepatitis and advanced fibrosis.
    Traussnigg S, Kienbacher C, Gajdošík M, Valkovič L, Halilbasic E, Stift J, Rechling C, Hofer H, Steindl-Munda P, Ferenci P, Wrba F, Trattnig S, Krššák M, Trauner M.
    Liver Int; 2017 Oct 01; 37(10):1544-1553. PubMed ID: 28544208
    [Abstract] [Full Text] [Related]

  • 10. Natural History of Simple Steatosis or Nonalcoholic Fatty Liver.
    De A, Duseja A.
    J Clin Exp Hepatol; 2020 Oct 01; 10(3):255-262. PubMed ID: 32405182
    [Abstract] [Full Text] [Related]

  • 11. FABP4 and MMP9 levels identified as predictive factors for poor prognosis in patients with nonalcoholic fatty liver using data mining approaches and gene expression analysis.
    Coilly A, Desterke C, Guettier C, Samuel D, Chiappini F.
    Sci Rep; 2019 Dec 24; 9(1):19785. PubMed ID: 31874999
    [Abstract] [Full Text] [Related]

  • 12. Transcriptomic differences in intra-abdominal adipose tissue in extremely obese adolescents with different stages of NAFLD.
    Sheldon RD, Kanosky KM, Wells KD, Miles L, Perfield JW, Xanthakos S, Inge TH, Rector RS.
    Physiol Genomics; 2016 Dec 01; 48(12):897-911. PubMed ID: 27764764
    [Abstract] [Full Text] [Related]

  • 13. Natural History of Non-Alcoholic Fatty Liver Disease: A Study With Paired Liver Biopsies.
    Reddy YK, Marella HK, Jiang Y, Ganguli S, Snell P, Podila PSB, Maliakkal B, Satapathy SK.
    J Clin Exp Hepatol; 2020 Dec 01; 10(3):245-254. PubMed ID: 32405181
    [Abstract] [Full Text] [Related]

  • 14. Hepatocyte nuclear receptor SHP suppresses inflammation and fibrosis in a mouse model of nonalcoholic steatohepatitis.
    Zou A, Magee N, Deng F, Lehn S, Zhong C, Zhang Y.
    J Biol Chem; 2018 Jun 01; 293(22):8656-8671. PubMed ID: 29666185
    [Abstract] [Full Text] [Related]

  • 15. Association of Adipose Tissue Inflammation With Histologic Severity of Nonalcoholic Fatty Liver Disease.
    du Plessis J, van Pelt J, Korf H, Mathieu C, van der Schueren B, Lannoo M, Oyen T, Topal B, Fetter G, Nayler S, van der Merwe T, Windmolders P, Van Gaal L, Verrijken A, Hubens G, Gericke M, Cassiman D, Francque S, Nevens F, van der Merwe S.
    Gastroenterology; 2015 Sep 01; 149(3):635-48.e14. PubMed ID: 26028579
    [Abstract] [Full Text] [Related]

  • 16. Metabolic drivers of non-alcoholic fatty liver disease.
    Bence KK, Birnbaum MJ.
    Mol Metab; 2021 Aug 01; 50():101143. PubMed ID: 33346069
    [Abstract] [Full Text] [Related]

  • 17. Metabolic and hepatic effects of liraglutide, obeticholic acid and elafibranor in diet-induced obese mouse models of biopsy-confirmed nonalcoholic steatohepatitis.
    Tølbøl KS, Kristiansen MN, Hansen HH, Veidal SS, Rigbolt KT, Gillum MP, Jelsing J, Vrang N, Feigh M.
    World J Gastroenterol; 2018 Jan 14; 24(2):179-194. PubMed ID: 29375204
    [Abstract] [Full Text] [Related]

  • 18. Similarities and differences between pediatric and adult nonalcoholic fatty liver disease.
    Crespo M, Lappe S, Feldstein AE, Alkhouri N.
    Metabolism; 2016 Aug 14; 65(8):1161-71. PubMed ID: 26961580
    [Abstract] [Full Text] [Related]

  • 19. Lipid zonation and phospholipid remodeling in nonalcoholic fatty liver disease.
    Hall Z, Bond NJ, Ashmore T, Sanders F, Ament Z, Wang X, Murray AJ, Bellafante E, Virtue S, Vidal-Puig A, Allison M, Davies SE, Koulman A, Vacca M, Griffin JL.
    Hepatology; 2017 Apr 14; 65(4):1165-1180. PubMed ID: 27863448
    [Abstract] [Full Text] [Related]

  • 20. Lifestyle intervention for morbid obesity: effects on liver steatosis, inflammation, and fibrosis.
    Hohenester S, Christiansen S, Nagel J, Wimmer R, Artmann R, Denk G, Bischoff M, Bischoff G, Rust C.
    Am J Physiol Gastrointest Liver Physiol; 2018 Sep 01; 315(3):G329-G338. PubMed ID: 29878845
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 105.